The Fort Worth Press - Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore

USD -
AED 3.672504
AFN 64.000368
ALL 80.660025
AMD 364.155001
ANG 1.790365
AOA 918.000367
ARS 1524.750402
AUD 1.417435
AWG 1.8
AZN 1.70397
BAM 1.716593
BBD 2.014833
BDT 123.096502
BGN 1.683441
BHD 0.377145
BIF 3013.033747
BMD 1
BND 1.278097
BOB 12.259622
BRL 5.188104
BSD 1.000307
BTN 95.794093
BWP 13.621802
BYN 3.022425
BYR 19600
BZD 2.011937
CAD 1.41495
CDF 2340.000362
CHF 0.828271
CLF 0.024357
CLP 961.770396
CNY 6.71325
CNH 6.734304
COP 3348.488173
CRC 454.820731
CUC 1
CUP 24.008426
CVE 96.778865
CZK 21.384404
DJF 178.136657
DKK 6.562804
DOP 59.49006
DZD 133.78604
EGP 51.914688
ERN 15
ETB 162.282003
EUR 0.87791
FJD 2.24725
FKP 0.754991
GBP 0.754689
GEL 2.61504
GGP 0.754991
GHS 11.618906
GIP 0.754991
GMD 73.503851
GNF 8797.998859
GTQ 7.639444
GYD 209.30355
HKD 7.84345
HNL 26.849519
HRK 6.613804
HTG 130.916751
HUF 320.61504
IDR 17914.1
ILS 3.04806
IMP 0.754991
INR 95.817504
IQD 1310.484048
IRR 1374575.000352
ISK 120.260386
JEP 0.754991
JMD 158.265678
JOD 0.70904
JPY 157.28504
KES 129.644095
KGS 87.448204
KHR 4068.10901
KMF 433.00035
KPW 900.000318
KRW 1355.185039
KWD 0.30864
KYD 0.833633
KZT 443.156186
LAK 22438.232325
LBP 89581.428007
LKR 330.293588
LRD 172.063018
LSL 16.32106
LTL 2.95274
LVL 0.60489
LYD 6.395752
MAD 9.599596
MDL 17.756616
MGA 4416.553298
MKD 54.043972
MMK 2099.795344
MNT 3598.18988
MOP 8.082152
MRU 40.243999
MUR 47.530378
MVR 15.450378
MWK 1734.585509
MXN 17.679204
MYR 4.074104
MZN 63.910377
NAD 16.32106
NGN 1326.380377
NIO 36.810462
NOK 9.50785
NPR 153.270725
NZD 1.749629
OMR 0.385571
PAB 1.000307
PEN 3.395971
PGK 4.456927
PHP 62.347038
PKR 277.197262
PLN 3.83775
PYG 5896.344407
QAR 3.646377
RON 4.629204
RSD 103.085092
RUB 84.346338
RWF 1478.474569
SAR 3.752852
SBD 8.000512
SCR 13.902664
SDG 601.503676
SEK 9.91775
SGD 1.277904
SHP 0.755002
SLE 24.650371
SLL 20969.491881
SOS 571.729495
SRD 37.667504
STD 20697.981008
STN 21.503489
SVC 8.753236
SYP 13002.000254
SZL 16.317198
THB 33.375038
TJS 9.228244
TMT 3.51
TND 2.961425
TOP 2.40776
TRY 48.942504
TTD 6.803879
TWD 31.728704
TZS 2654.934831
UAH 44.794751
UGX 3918.023434
UYU 40.075482
UZS 11839.206565
VES 852.43145
VND 25976
VUV 118.485868
WST 2.745655
XAF 575.871484
XAG 0.015553
XAU 0.000233347179
XCD 2.70255
XCG 1.80287
XDR 0.707052
XOF 575.871484
XPF 104.673717
YER 236.650363
ZAR 16.304245
ZMK 9001.203584
ZMW 19.513758
ZWL 321.999592
SSP 5712.5919
MXV 2.00344
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore

LAFAYETTE, LA / ACCESS Newswire / September 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that Michael Moore, President of Viemed, has adopted an automatic securities disposition plan (the "ASDP") relating to common shares of the Company.

Text size:

Under applicable securities laws, insiders are subject to limits on their ability to sell shares. ASDPs permit trades to be made in accordance with pre-arranged instructions given when the insider is not in possession of any material undisclosed information, on an automatic basis, regardless of any subsequent material non-public information the insider receives. Once an ASDP is established, the insider is not permitted to exercise any further discretion or influence over how dispositions will occur under the ASDP.

The ASDP was established in accordance with applicable United States and Canadian securities laws and Viemed's internal policies. The ASDP consists of a pre-arranged trading plan administered by Morgan Stanley Smith Barney LLC ("Morgan Stanley") pursuant to Rule 10b5-1 under the U.S. Securities Exchange Act of 1934 with respect to common shares of Viemed held by Moore Faster LLC, an entity controlled by Mr. Moore. Mr. Moore has provided pre-arranged instructions in writing to Morgan Stanley. The ASDP prohibits Mr. Moore from disclosing to Morgan Stanley any information concerning the Company that might influence the execution of the ASDP.

The ASDP was adopted in accordance with Viemed's insider trading policy and at a time when Mr. Moore was not aware of any material fact or material change relating to Viemed that had not been generally disclosed.

Up to 246,000 common shares may be sold under the ASDP pursuant to predetermined trading instructions over an approximately one-year term ending November 30, 2027. The shares subject to the ASDP represent less than 11% of the common shares beneficially owned directly and indirectly by Mr. Moore as disclosed in the Company's most recent proxy statement. Sales may commence as early as December 24, 2026, following the applicable waiting period under Rule 10b5-1. Sales under the ASDP are subject to a minimum floor price.

The arrangement has been authorized by the Company and contains meaningful restrictions on the ability of Mr. Moore and Moore Faster LLC to amend, suspend or terminate the ASDP. Any amendment, suspension or termination of the ASDP will be disclosed in accordance with applicable securities laws.

Dispositions by or on behalf of Mr. Moore under the ASDP will be reported in accordance with applicable securities laws. Information regarding the ASDP and transactions thereunder may be accessed on SEDI at www.sedi.ca and www.sec.gov.

This announcement is made pursuant to the recommended practices set forth in Staff Notice 55-317- Automatic Securities Disposition Plans of the Canadian Securities Administrators and will be available under the Company's SEDAR+ profile at www.sedarplus.ca.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is a provider of home medical equipment and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. Viemed's model emphasizes efficient, high-quality care delivered in the home through a combination of high-touch clinical support and technology-enabled services, including therapy, education, and counseling provided by our clinical practitioners. For more information, visit our website at www.viemed.com.

For further information, please contact:

Investor Relations
[email protected]

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
(337) 504-3802

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or "forward-looking information" as such term is defined in applicable Canadian securities legislation (collectively, "forward-looking statements"). Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "potential", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes", "projects", or the negatives thereof or variations of such words and phrases or statements that certain actions, events or results "will", "should", "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative of these terms or comparable terminology. All statements other than statements of historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance, including the expected operation, term, timing and number of dispositions under the ASDP and the restrictions on Mr. Moore's ability to amend, suspend or terminate the ASDP, are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking statements to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation. those risk factors discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and with the securities regulatory authorities in certain provinces of Canada available at www.sedarplus.ca. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking statements prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking statements are expressly qualified in their entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking statements. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.

SOURCE: Viemed Healthcare, Inc.



View the original press release on ACCESS Newswire

S.Weaver--TFWP